管理双重依赖:同时低剂量布普伦诺芬诱导和快速巴比塔尔缩小的案例研究
Brent Schnipke1, Gayane Archer1, Veronika Hanko1
1McGaw Medical Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Journal of psychoactive drugs
|January 15, 2025
概括
这项案例研究表明,同时低剂量布普伦诺芬诱导和快速降低巴比特尔可以在医院环境中安全地管理同时发生的阿片类药物和二胺类药物依赖.
科学领域:
- 成 药物 药物 药物 药物
- 药理学 药理学是指药理学的学科.
- 临床案例研究 临床案例研究
背景情况:
- 同时出现的物质使用障碍在医疗保健中提出了管理挑战.
- 对于联合阿片类药物和二胺类药物依赖的并发药理疗法存在有限的研究.
研究的目的:
- 描述一种同时治疗阿片类药物和二胺类药物依赖的案例.
- 评估同时低剂量布普伦诺芬诱导和快速巴比特的可行性和安全性.
主要方法:
- 一名接受慢性甲维持疗法和处方阿尔普拉佐拉姆的患者同时接受了低剂量的布普伦诺芬诱导和快速降低的巴比特.
- 管理是在医院环境中进行的.
主要成果:
- 同时的药理管理被患者容忍得很好.
- 治疗以最小的并发症完成.
- 患者在治疗后有资格获得他们喜欢的处置.
结论:
- 同时低剂量的布普伦诺芬诱导和快速的巴比特缩是一种可行的策略,用于管理复杂的同时发生的物质使用障碍.
- 这种方法可以促进医院环境中的患者处置.
- 需要进一步的研究,以在更大的队列中探索这种治疗模式.
相关概念视频
01:14CNS Depressants: Barbiturates and Benzodiazepines
217
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
217
01:20Sedatives and Hypnotics Drugs: Barbiturates
192
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
192
01:24Parenteral Anesthetics: Overview
96
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
96
01:20Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
78
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
78
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
216
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
216